Eliem Therapeutics Operating Expenses 2021-2024 | CLYM
Eliem Therapeutics operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Eliem Therapeutics Annual Operating Expenses
(Millions of US $) |
| 2023 |
$40 |
| 2022 |
$45 |
| 2021 |
$36 |
| 2020 |
$21 |
Eliem Therapeutics Quarterly Operating Expenses
(Millions of US $) |
| 2024-06-30 |
$56 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$5 |
| 2023-09-30 |
$5 |
| 2023-06-30 |
$7 |
| 2023-03-31 |
$23 |
| 2022-12-31 |
$10 |
| 2022-09-30 |
$9 |
| 2022-06-30 |
$14 |
| 2022-03-31 |
$13 |
| 2021-12-31 |
$11 |
| 2021-09-30 |
$9 |
| 2021-06-30 |
$9 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
|
| 2020-09-30 |
$2 |
| 2020-06-30 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
